Upon binding to a receptor, agonists and antagonists can induce distinct biological functions and thus lead to significantly different pharmacological responses. Thus, in silico prediction or in vitro characterization of ligand agonistic or antagonistic functionalities is an important step toward identifying specific pharmacological therapeutics. In this study, we investigated the molecular properties of agonists and antagonists of human 5-hydroxytryptamine receptor subtype 1A (5-HT1A). Subsequently, intrinsic functions of these ligands (agonists/antagonists) were modeled by support vector machine (SVM), using five 2D molecular fingerprints and the 3D Topomer distance. Five kernel functions, including linear, polynomial, RBF, Tanimoto and a...
Introduction of a new drug to the market is a challenging and resource-consuming process. Predictive...
The 5-hydroxytryptamine (5-HT1A) receptors represent an attractive target in drug discovery. In part...
5-HT(1A) serotonin and D1 dopamine receptor agonists have been postulated to be able to improve nega...
Upon binding to a receptor, agonists and antagonists can induce distinct biological functions and th...
Upon binding to a receptor, agonists and antagonists can induce distinct biological functions and th...
In the present work, the support vector machine (SVM) and Adaboost-SVM have been used to develop a c...
A computational procedure to search for selective ligands for structurally related protein targets w...
The pharmacologically characterized receptor subtype of the serotonin family, the 5HT1A receptor is ...
ABSTRACT: The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has been an attractive target for t...
Despite its remarkable importance in the arena of drug design, serotonin 1A receptor (5-HT1A) has be...
The identification of subtype-selective GPCR (G-protein coupled receptor) ligands is a challenging t...
In Chapter 1 a review of the 5-HT1B receptor is conducted, describing physiological and pathological...
SummaryThe development of safe and effective drugs relies on the discovery of selective ligands. Ser...
Objective: Structural characterization of 5-hydroxytryptamine (5-HT)2A receptor in homo sapiens usin...
International audience5-Hydroxytryptamine subtype-4 (5-HT(4)) receptors have stimulated considerable...
Introduction of a new drug to the market is a challenging and resource-consuming process. Predictive...
The 5-hydroxytryptamine (5-HT1A) receptors represent an attractive target in drug discovery. In part...
5-HT(1A) serotonin and D1 dopamine receptor agonists have been postulated to be able to improve nega...
Upon binding to a receptor, agonists and antagonists can induce distinct biological functions and th...
Upon binding to a receptor, agonists and antagonists can induce distinct biological functions and th...
In the present work, the support vector machine (SVM) and Adaboost-SVM have been used to develop a c...
A computational procedure to search for selective ligands for structurally related protein targets w...
The pharmacologically characterized receptor subtype of the serotonin family, the 5HT1A receptor is ...
ABSTRACT: The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has been an attractive target for t...
Despite its remarkable importance in the arena of drug design, serotonin 1A receptor (5-HT1A) has be...
The identification of subtype-selective GPCR (G-protein coupled receptor) ligands is a challenging t...
In Chapter 1 a review of the 5-HT1B receptor is conducted, describing physiological and pathological...
SummaryThe development of safe and effective drugs relies on the discovery of selective ligands. Ser...
Objective: Structural characterization of 5-hydroxytryptamine (5-HT)2A receptor in homo sapiens usin...
International audience5-Hydroxytryptamine subtype-4 (5-HT(4)) receptors have stimulated considerable...
Introduction of a new drug to the market is a challenging and resource-consuming process. Predictive...
The 5-hydroxytryptamine (5-HT1A) receptors represent an attractive target in drug discovery. In part...
5-HT(1A) serotonin and D1 dopamine receptor agonists have been postulated to be able to improve nega...